| Size & multiples | |||
| Market Cap | SEK 28.41B | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 110.41× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | — | Buyback Yield | — |
| Owner Earnings Yield | — | Shareholder Yield | — |
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | −0.46 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 1.69% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows latest annual · EPS TTM — · revenue TTM SEK 257.4M · FCF TTM — (in SEK)
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| Dividend Yield | 0.0% | 1.1% | 0.2%–2.4% | 22 ↓weak |
| Net Margin | -68.8% | -21.2% | -325.3%–7.2% | 40 ↓weak |
| Operating Margin | -88.8% | -34.5% | -552.0%–8.0% | 41 ↓weak |
| ROE | -18.2% | -36.8% | -92.5%–4.5% | 61 ↑strong |
